ETHYOL® (amifostine) is a prescription drug given by injection prior to each postoperative radiation treatment session for head and neck cancer. ETHYOL is used to lower the rate of moderate to severe xerostomia (zee-roh-STOW-mee-uh) (dry mouth). It is used in patients receiving radiation therapy following surgery for head and neck cancer when the radiation area includes a large part of the parotid glands (the largest of the salivary glands).

ETHYOL is not approved for use in combination with radiation therapy other than as described above.

At ETHYOL.com you can find answers to

  • Why would my doctor prescribe ETHYOL?
  • What are the benefits of adding ETHYOL to postoperative radiation therapy?
  • How should I prepare for receiving ETHYOL?
  • What tools and resources are available?

The information on this Web site cannot replace the advice of your doctor. Be sure to discuss any questions about ETHYOL with your health care team. Your health care team will recommend the best course of treatment for you after assessing your particular medical needs.

Scroll down for Important Safety Information